主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | Pzena Investment Management, Llc | 是 | 7086.60万 | 13.80% |
|
|
-- |
| 2 | 领航集团有限公司 | 是 | 6015.51万 | 11.70% | 不变 | 不变 | -- |
| 3 | Dodge & Cox | 是 | 5739.64万 | 11.20% |
|
|
-- |
| 4 | BlackRock Portfolio Management LLC | 是 | 4492.53万 | 8.70% | 新增 | 新增 | -- |
| 5 | 贝莱德集团公司 | 是 | 3862.14万 | 7.50% |
|
|
-- |
| 6 | FMR LLC | 是 | 3481.18万 | 6.80% | 新增 | 新增 | -- |
| 7 | Jose E. Almeida | 否 | 290.69万 | 0.57% | 新增 | 新增 | 0.5650% |
| 8 | Reazur Rasul | 否 | 27.23万 | 0.05% | 新增 | 新增 | 0.0529% |
| 9 | David S. Rosenbloom | 否 | 19.96万 | 0.04% | 新增 | 新增 | 0.0388% |
| 10 | Joel Grade | 否 | 18.16万 | 0.04% | 新增 | 新增 | 0.0353% |
| 11 | Heather Knight | 否 | 6.25万 | 0.01% | 新增 | 新增 | 0.0121% |
| 12 | Brent Shafer | 否 | 5.99万 | 0.01% | 新增 | 新增 | 0.0116% |
| 13 | Amy A. Wendell | 否 | 4.85万 | 0.0094% | 新增 | 新增 | 0.0094% |
| 14 | Maria Cecilia Soriano | 否 | 4.82万 | 0.0094% | 新增 | 新增 | 0.0094% |
| 15 | Stephen N. Oesterle | 否 | 3.74万 | 0.0073% | 新增 | 新增 | 0.0073% |
| 16 | Alok Sonig | 否 | 3.54万 | 0.0069% | 新增 | 新增 | 0.0069% |
| 17 | Patricia B. Morrison | 否 | 1.61万 | 0.0031% | 新增 | 新增 | 0.0031% |
| 18 | Jeffrey A. Craig | 否 | 1.08万 | 0.0021% | 新增 | 新增 | 0.0021% |
| 19 | William A. Ampofo II | 否 | 1.03万 | 0.0020% | 新增 | 新增 | 0.0020% |
| 20 | Nancy M. Schlichting | 否 | 0.81万 | 0.0016% | 新增 | 新增 | 0.0016% |
| 21 | David S. Wilkes | 否 | 0.29万 | 0.0006% | 新增 | 新增 | 0.0006% |
| 22 | Andrew P. Hider | 否 | 0.22万 | 0.0004% | 新增 | 新增 | 0.0004% |
| 23 | Michael R. McDonnell | 否 | 0.18万 | 0.0004% | 新增 | 新增 | 0.0004% |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2026-03-06 | Grade Joel T. |
|
27.17 | 17.69 | 是 | EVP and CFO |
| 2026-03-06 | Rasul Reazur |
|
12.56 | 17.69 | 是 | EVP,Group Pres,Healthcare |
| 2026-03-06 | Rosenbloom David S. |
|
13.82 | 17.69 | 是 | EVP and General Counsel |
| 2026-03-06 | Soriano Maria Cecilia |
|
7.50 | 17.69 | 是 | Group Pres., ITT & Pharma. |
| 2026-03-06 | Zielinski Anita A |
|
4.63 | 17.69 | 是 | SVP, CAO and Controller |
| 2026-03-02 | Rasul Reazur |
|
13.82 | 19.69 | 是 | EVP,Group Pres,Healthcare |
| 2026-02-27 | Zielinski Anita A |
|
4.82 | 0.00 | 是 | SVP, CAO and Controller |
| 2026-02-27 | Rosenbloom David S. |
|
14.62 | 0.00 | 是 | EVP and General Counsel |
| 2026-02-27 | Rosenbloom David S. |
|
14.48 | 19.69 | 是 | EVP and General Counsel |
| 2026-02-27 | Grade Joel T. |
|
27.98 | 0.00 | 是 | EVP and CFO |
| 2026-02-27 | Soriano Maria Cecilia |
|
7.97 | 0.00 | 是 | Group Pres., ITT & Pharma. |
| 2026-02-27 | Soriano Maria Cecilia |
|
7.79 | 19.69 | 是 | Group Pres., ITT & Pharma. |
| 2026-02-27 | Carlisle Cynthia |
|
1.78 | 0.00 | 是 | Executive Vice President, CHRO |
| 2026-02-27 | Carlisle Cynthia |
|
2.97 | 0.00 | 是 | Executive Vice President, CHRO |
| 2026-02-27 | Hider Andrew P. |
|
57.22 | 0.00 | 是 | President and CEO |
| 2026-02-13 | McDonnell Michael R. |
|
0.18 | 0.00 | 是 | -- |
| 2026-02-09 | Grade Joel T. |
|
24.60 | 0.00 | 是 | EVP and CFO |
| 2026-02-09 | Grade Joel T. |
|
23.69 | 21.73 | 是 | EVP and CFO |
| 2026-02-09 | Rasul Reazur |
|
14.56 | 0.00 | 是 | EVP,Group Pres,Healthcare |
| 2026-02-09 | Rasul Reazur |
|
13.98 | 21.73 | 是 | EVP,Group Pres,Healthcare |
| 2026-02-09 | Rosenbloom David S. |
|
12.47 | 0.00 | 是 | EVP and General Counsel |
| 2026-02-09 | Soriano Maria Cecilia |
|
5.60 | 21.73 | 是 | Group Pres., ITT & Pharma. |
| 2026-02-09 | Rosenbloom David S. |
|
11.95 | 21.73 | 是 | EVP and General Counsel |
| 2026-02-09 | Soriano Maria Cecilia |
|
5.69 | 0.00 | 是 | Group Pres., ITT & Pharma. |
| 2025-12-12 | Mason Jeanne K |
|
19.99 | 19.15 | 是 | EVP, Chief HR Officer |
| 2025-12-01 | Grade Joel T. |
|
21.52 | 19.08 | 是 | EVP and CFO |
| 2025-09-02 | Borzi James W |
|
7.19 | 24.17 | 是 | EVP,Chief Supply Chain Officer |
| 2025-09-02 | Grade Joel T. |
|
22.26 | 0.00 | 是 | EVP and CFO |
| 2025-09-02 | Hider Andrew P. |
|
23.62 | 0.00 | 是 | President and CEO |
| 2025-09-02 | Hider Andrew P. |
|
36.81 | 0.00 | 是 | President and CEO |
| 2025-09-02 | Sonig Alok |
|
12.82 | 24.17 | 是 | EVP,Group President,Pharma |
| 2025-08-19 | Shafer David Brent |
|
5.94 | 24.33 | 是 | Chair of the Board |
| 2025-06-02 | Rosenbloom David S. |
|
10.63 | 29.55 | 是 | EVP and General Counsel |
| 2025-05-06 | Craig Jeffrey A |
|
1.07 | 0.00 | 是 | -- |
| 2025-05-06 | RUSCKOWSKI STEPHEN H |
|
1.65 | 0.00 | 是 | -- |
| 2025-05-06 | Oesterle Stephen N. |
|
3.58 | 0.00 | 是 | -- |
| 2025-05-06 | MORRISON PATRICIA |
|
2.91 | 0.00 | 是 | -- |
| 2025-05-06 | Ampofo William A. II |
|
1.73 | 0.00 | 是 | -- |
| 2025-05-06 | Smith Cathy R |
|
3.03 | 0.00 | 是 | -- |
| 2025-05-06 | SCHLICHTING NANCY M |
|
2.19 | 0.00 | 是 | -- |
| 2025-05-06 | Wendell Amy McBride |
|
3.12 | 0.00 | 是 | -- |
| 2025-05-06 | Wilkes David S. |
|
2.39 | 0.00 | 是 | -- |
| 2025-03-06 | Borzi James W |
|
6.31 | 35.44 | 是 | EVP,Chief Supply Chain Officer |
| 2025-03-06 | Borzi James W |
|
7.31 | 0.00 | 是 | EVP,Chief Supply Chain Officer |
| 2025-03-06 | Mason Jeanne K |
|
18.40 | 35.44 | 是 | EVP, Chief HR Officer |
| 2025-03-06 | Mason Jeanne K |
|
19.97 | 0.00 | 是 | EVP, Chief HR Officer |
| 2025-03-06 | Grade Joel T. |
|
8.89 | 35.44 | 是 | EVP and CFO |
| 2025-03-06 | Grade Joel T. |
|
11.84 | 0.00 | 是 | EVP and CFO |
| 2025-03-06 | Knight Heather |
|
14.17 | 35.44 | 是 | EVP, Chief Operating Officer |
| 2025-03-06 | Knight Heather |
|
17.74 | 0.00 | 是 | EVP, Chief Operating Officer |
| 2025-03-06 | Rasul Reazur |
|
9.84 | 35.44 | 是 | EVP,Group Pres,Healthcare |
| 2025-03-06 | Rasul Reazur |
|
12.46 | 0.00 | 是 | EVP,Group Pres,Healthcare |
| 2025-03-06 | Rosenbloom David S. |
|
10.48 | 35.44 | 是 | EVP and General Counsel |
| 2025-03-06 | Rosenbloom David S. |
|
12.24 | 0.00 | 是 | EVP and General Counsel |
| 2025-03-06 | Sonig Alok |
|
10.03 | 35.44 | 是 | EVP,Group President,Pharma |
| 2025-03-06 | Sonig Alok |
|
13.03 | 0.00 | 是 | EVP,Group President,Pharma |
| 2025-03-06 | Zielinski Anita A |
|
1.71 | 0.00 | 是 | SVP, CAO and Controller |
| 2025-03-03 | Knight Heather |
|
15.53 | 34.86 | 是 | EVP, Chief Operating Officer |
| 2025-03-03 | Borzi James W |
|
6.64 | 34.86 | 是 | EVP,Chief Suppy Chain Officer |
| 2025-03-03 | Sonig Alok |
|
11.12 | 34.86 | 是 | EVP,Group President,Pharma |
| 2025-03-03 | Mason Jeanne K |
|
18.83 | 34.86 | 是 | EVP, Chief HR Officer |
| 2025-03-03 | Rosenbloom David S. |
|
10.97 | 34.86 | 是 | EVP and General Counsel |
| 2025-03-03 | Rasul Reazur |
|
10.77 | 34.86 | 是 | EVP,Group Pres,Healthcare |
| 2025-02-05 | Shafer David Brent |
|
8.98 | 0.00 | 是 | Interim CEO and Chair |
| 2025-01-31 | Toth Christopher A. |
|
10.52 | 32.56 | 是 | EVP, Group Pres, Kidney Care |
| 2024-12-31 | Toth Christopher A. |
|
18.39 | 29.16 | 是 | EVP,Group Pres, Kidney Care |
| 2024-12-13 | ALMEIDA JOSE E |
|
24.36 | 30.32 | 是 | Chairman, CEO, President |
| 2024-12-02 | Rasul Reazur |
|
10.91 | 33.55 | 是 | EVP,Group Pres,Healthcare |
| 2024-12-02 | Knight Heather |
|
15.77 | 33.55 | 是 | EVP, Group Pres, Med Products |
| 2024-12-02 | Grade Joel T. |
|
9.25 | 33.55 | 是 | EVP and CFO |
| 2024-09-09 | Craig Jeffrey A |
|
0.35 | 0.00 | 是 | -- |
| 2024-09-03 | Borzi James W |
|
6.69 | 37.85 | 是 | EVP,Chief Supply Chain Officer |
| 2024-09-03 | Sonig Alok |
|
11.16 | 37.85 | 是 | EVP,Group President, Pharma |
| 2024-06-03 | Toth Christopher A. |
|
21.33 | 34.08 | 是 | EVP,Group Pres, Kidney Care |
| 2024-06-03 | Rosenbloom David S. |
|
10.86 | 34.08 | 是 | EVP and General Counsel |
| 2024-05-07 | WILVER PETER M |
|
1.33 | 0.00 | 是 | -- |
| 2024-05-07 | Wendell Amy McBride |
|
2.39 | 0.00 | 是 | -- |
| 2024-05-07 | Wilkes David S. |
|
1.63 | 0.00 | 是 | -- |
| 2024-05-07 | Smith Cathy R |
|
2.25 | 0.00 | 是 | -- |
| 2024-05-07 | Shafer David Brent |
|
1.33 | 0.00 | 是 | -- |
| 2024-05-07 | RUSCKOWSKI STEPHEN H |
|
0.91 | 0.00 | 是 | -- |
| 2024-05-07 | Oesterle Stephen N. |
|
2.79 | 0.00 | 是 | -- |
| 2024-05-07 | SCHLICHTING NANCY M |
|
1.43 | 0.00 | 是 | -- |
| 2024-05-07 | MORRISON PATRICIA |
|
2.14 | 0.00 | 是 | -- |
| 2024-05-07 | Ampofo William A. II |
|
0.98 | 0.00 | 是 | -- |